Blog - Page 3704 of 5550

FridayMay 07, 2010 2:10 pm

Las Vegas Railway Express (XTRN.OB) Hits Milestone with Acquisition of First Passenger Train Railcar Set

Las Vegas Railway Express, Inc. has acquired its first set of passenger railcars for its Las Vegas to Los Angeles “X Train” project. After nearly two years in research and development on the logistics, the planning process has been nearly completed. This is the first major step in achieving their vision of a “Vegas style” passenger train system that will tap into the 12 million people who make the trip from Los Angeles to Las Vegas every year. The agreement for the purchase of the railcar set has been executed with Transportation Management Services with delivery to Las Vegas Railway…

FridayMay 07, 2010 2:07 pm

Quick-Med Technologies, Inc. (QMDT.OB) Obtains Patent for NIMBUS(R ) Technology

One company that is starting to turn the heads of investors is the Gainesville, Florida based Quick-Med Technologies. Quick-Med is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. One of the major assets of Quick-Med is NIMBUS technology which employs a safe, eco-friendly active agent that remains in full concentration on any of safer substrates. Quick-Med has earned national recognition for the development of their NIMBUS applications in several other advanced wound dressing formats including adhesives, foams, hydrogels, films, and hydrocolloids. Today, Quick-Med took a major step towards enhancing their future with the…

FridayMay 07, 2010 11:17 am

QuantRx Biomedical Corp. (QTXB.OB) Enters Veterinary Diagnostics Market in Europe

QuantRX® Biomedical Corp., a U.S. provider of innovative products for advanced diagnosis of serious disease and health conditions, today announced its very first entry into the animal healthcare market, with a two-year agreement with VetRed BV, a fast growing participant in the European veterinarian supplies market, for the distribution of QuantRx products. The agreement also marks the company’s first move into the EC market, second only to the U.S. in the number of feline and canine pets. QuantRx is also completing veterinary product distribution agreements in North America. VetRed, based in the Netherlands, will market QuantRx’s newly developed thyroid panel…

FridayMay 07, 2010 11:10 am

NewCardio, Inc. (NWCI.OB) to Offer Live Demo of CardioBip Handheld ECG Monitor

NewCardio, Inc. of Silicon Valley, which is hard at work commercializing a revolutionary new series of electrocardiography (ECG) products for diagnosing the health of the human heart, announced today the showcasing of its Cardio3KG™ (3-D ECG imaging software solution), QTinno™ (QT interval analytical suite), and the unveiling of its new patented, handheld wireless device, the CardioBip™, which can easily be used by anyone and generates the industry standard 12 lead ECG data. Both will be displayed this May 12-15 in booth #2147 at the Heart Rhythm Society’s (HRS) 31st Annual Scientific Sessions conference at the Denver Convention Center in Colorado.…

FridayMay 07, 2010 11:07 am

Crude Oil Prices Have a Rough Week

Crude oil prices were rather volatile on Friday morning, following an 11 percent sell-off so far this week. Oil prices have fallen from an 18-month high of $87.15, which was hit on Monday. Oil was driven lower by the continued turmoil in Europe and specifically the debt situation in Greece. The Euro itself hit a 14-month low this week at about $1.25 versus the US dollar. Concerns continue to grow that the debt crisis will spread from Greece to other weak European economies including Portugal, Spain, Italy and Ireland. If these countries are forced to make drastic budget cuts, it…

FridayMay 07, 2010 11:05 am

Helix BioMedix, Inc. (HXBM.OB) Reports First Quarter 2010 Financial Results

Helix BioMedix Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Applications for the company's peptides include anti-aging cosmeceutical skin care and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. The company today announced financial results for its first quarter 2010, which ended March 31, 2010. Revenue for the first quarter of 2010 was approximately $70,000 compared to revenue of about $87,000 in the prior year first quarter. Gross margin improved to 64.9% in the first quarter compared…

FridayMay 07, 2010 8:52 am

American Sierra Gold Corp. (AMNP.OB) Video Chart for Friday, May 7, 2010

The AMNP chart is at a point where it is time to make a decision. Many of the indicators have set-up nicely over the last couple months and now are at a “make-or-break” point. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=392 Let us hear your thoughts below:

FridayMay 07, 2010 8:40 am

Micro Identification Technologies, Inc. (MMTC.OB) Showcased as ‘Shining a Light on Food-Borne Illnesses’ by HealthNewsDigest.com

Micro Identification Technologies, Inc. recently announced its profile in HealthNewsDigest.com. The article featuring the company is an excellent source for readers and experts who want to learn more about the importance of innovative ways to protect food safety. Written by biochemist Michael D. Shaw, the article showcases MIT's proprietary technology and emphasis on preventing food-borne illnesses. Readers can view the article at: http://www.healthnewsdigest.com/news/contributing%20columnist0/Shining_A_Light_On_Food-Borne_Illnesses.shtml Mr. Shaw wrote, "Two distinct advantages of [MIT's] method are the very quick identification time (less than 10 minutes), and the low cost ($0.10 per test). 23 species can now be identified with this technique. An upcoming…

FridayMay 07, 2010 8:27 am

Stellar Pharmaceuticals, Inc. (SLXCF.OB) Signs Licensing Agreement with medac GmbH

Canadian pharmaceutical developer Stellar Pharmaceuticals Inc. reported that they signed a licensing agreement with medac GmbH for the distribution and sale of one of its lead products, Uracyst®. The product, a sterile sodium chondrotin solution used to treat interstitial cystitis/painful bladder syndrome, will be marketed in Germany and Austria; there, the product is trademarked as Uropol®. With the approved CE mark for the product already in place, the company expects that medac will launch Uropol® in the third quarter of 2010. The agreement has an initial five-year term with additional two-year renewal periods, and under the terms of the agreement,…

FridayMay 07, 2010 8:26 am

MedaSorb Technologies Corp. (CTSO.OB) Announces Company Name Change and New Ticker Symbol

MedaSorb Technologies Corporation announced yesterday that they have formally changed their company name to CytoSorbents Corporation. Along with this corporate name change, the new ticker symbol for the Company will be CTSO.OB, effective at the open of business on Friday, May 7, 2010. MedaSorb Technologies Corporation formerly traded under the symbol MSBT.OB. CytoSorbents Corporation, and their operating subsidiary CytoSorbents, Inc., is a therapeutic device company. They are in clinical trials to treat severe sepsis with a novel blood purification device called CytoSorb™. Severe sepsis often goes by the name "overwhelming infection." The triggering of severe sepsis is usually by bacterial…

Site Search

Company Search